Robert Ferris

UPMC Endowed Professor

University of Pittsburgh School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (11)

Hisham Mehanna

University of Birmingham

UNITED KINGDOM

View details

Jing Wang

Professor

UNITED STATES

View details

Huaibin Ge

University of Pittsburgh

UNITED STATES

View details

Christophe Le Tourneau

Head of Early Phase Clinical Trials

Institut Curie

FRANCE

View details

Barbara Burtness

Professor

Yale University School of Medicine

UNITED STATES

View details

Marc Ernstoff

Chief

National Institutes of Health

UNITED STATES

View details

Tim Greten

National Institutes of Health

UNITED STATES

View details

Meghan Turner

Assistant Professor

UNITED STATES

View details

Neil H. Segal

Weill Cornell Medicine

UNITED STATES

View details

Makoto Tahara

JAPAN

View details

Kevin Contrera

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Ferris

Research Interests

Explore related searches

Contact this professor

Articles (13)

Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design

The role of surgery and deescalation for HPV‐related oropharyngeal cancer

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit

Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes

The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

The Nasoseptal Flap for Reconstruction of Lateral Oropharyngectomy Defects: A Clinical Series

Reply to A.S. Garden

Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma

Collaborators (11)

Hisham Mehanna

Jing Wang

Huaibin Ge

Christophe Le Tourneau

Barbara Burtness

Marc Ernstoff

Tim Greten

Meghan Turner

Neil H. Segal

Makoto Tahara

Kevin Contrera

Make your next move.